Indication
Lymphogranuloma venereum
Lymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis*. Read more about Lymphogranuloma venereum
222 drugs 110 manufacturers
Drugs that treat it
Common Lymphogranuloma venereum therapies.
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis*.
The pathogen preferentially targets regional lymphatic tissues and mucosal surfaces, classically producing a transient, painless primary genital ulcer followed by painful inguinal or femoral lymphadenopathy with suppurative bubo formation.
Particularly among men who have sex with men, it frequently manifests as severe, invasive proctocolitis marked by hemorrhagic rectal discharge, tenesmus, and constipation.
If left untreated, chronic lymphatic obstruction and persistent inflammation can result in irreversible complications, including genital elephantiasis, fistulas, and colorectal strictures.
- cdc.gov
Lymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis* The pathogen preferentially targets regional lymphatic tissues and mucosal surfaces, classically producing a transient, painless primary genital ulcer followed by painful inguinal or femoral lymphadenopathy with suppurative bubo formation Particularly among men who have sex with men, it frequently manifests as severe, invasive proctocolitis mark...
- nih.gov
Lymphogranuloma venereum is a systemic sexually transmitted infection caused by invasive L1, L2, or L3 serovars of the bacterium *Chlamydia trachomatis* The pathogen preferentially targets regional lymphatic tissues and mucosal surfaces, classically producing a transient, painless primary genital ulcer followed by painful inguinal or femoral lymphadenopathy with suppurative bubo formation
- nih.gov
The pathogen preferentially targets regional lymphatic tissues and mucosal surfaces, classically producing a transient, painless primary genital ulcer followed by painful inguinal or femoral lymphadenopathy with suppurative bubo formation If left untreated, chronic lymphatic obstruction and persistent inflammation can result in irreversible complications, including genital elephantiasis, fistulas, and colorectal strictures
Personalize your experience
Follow Lymphogranuloma venereum and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.